"We will increase plasma supply to Bern from our own extensive
collection facilities, and may purchase additional recovered plasma
from sources other than the Red Cross as appropriate," Turner
continued. Below are the top three questions:

1.
"We are currently analyzing the data to understand why this study differs
from the long-term improvement of the more than 2700 patients who were treated
previously in Venezuela," said Jose O'Daly, M.

anyone myasthenia

Astralis Ltd.

group answers

About ZLB Behring

ZLB Behring is a global leader in the plasma protein
biotherapeutics industry.
Additionally, ZLB Behring operates one of the world's largest,
fully-owned plasma collection networks.
The questions, available at http://www. In the study, Psoraxine was found to be safe and well tolerated.D. There can be no assurance that Psoraxine(R)
will be successfully developed or manufactured, or that final results of human
clinical trials will result in the regulatory approvals required to market
products, or that final regulatory approval will be received in a timely
manner, if at all, or that patient and physician acceptance of this product
will be achieved.

aids answers

org, give women an easy
reference to better prepare themselves for visits with their physicians and
one place to keep all the answers .

auto answers

About Blue Cross Blue Shield of Arizona
Blue Cross Blue Shield of Arizona, an independent licensee of the Blue
Cross and Blue Shield Association, is the only major not-for-profit and local
health insurance company in Arizona. We also remain committed to the use of our technology platform
in other dermatological diseases, as well as in other therapeutic areas
including arthritis.

diseases groups

Business Editors/Health Editors

KING OF PRUSSIA, Pa.ZLBBehring. To help Arizona women better understand
their health, Blue Cross Blue Shield of Arizona (BCBSAZ) and Healthy Women for
a Lifetime (HWL) are providing a list of the top 10 questions that women can
ask their health care providers .
(OTC Bulletin Board: ASTR) today announced that the Phase II study of its
novel immuno-stimulatory product for the treatment of Psoriasis did not meet
the primary study endpoint upon completion of the treatment phase of the
study. undertakes no obligation to revise or
update any forward-looking statement herein to reflect events or circumstances
after the date of this release.

aids symptoms

----In a
development that will free manufacturing capacity for its branded
plasma therapeutics, ZLB Behring, a CSL Limited Company (CSL. The company was founded in 1939 and has
more than 1,500 employees providing support to members statewide with offices
in Phoenix, Flagstaff and Tucson. For information about the company 's
products, services and community programs such as WalkingWorks, please visit
http://www.,
including with respect to the objectives, intentions, and expectations
relating to clinical studies.

deficiency auto

"With these plans, ZLB Behring intends to assure that its
supply of IVIG to the U."
Women across the state are also invited to visit the BCBSAZ Web site,
http://www.azblue.

disorders auto

com

FAIRFIELD , N., Astralis Ltd.

auto immune

"Meeting patient needs for immunoglobulin therapy and other
services is a key focus of our company, as the leading immune globulin
provider worldwide," said Peter Turner, President of ZLB Behring.

Astralis Phase II Study of Psoraxine for Psoriasis Does Not Meet Primary Study Endpoint

Initial analysis of the
preliminary data showed no statistically significant clinical improvement
compared to placebo following six injections over twelve weeks of treatment.

myositis deficiency

Under that agreement, ZLB Behring manufactures
Panglobulin(R) immunoglobulin and Human Albumin for the Red Cross at
its Bern, Switzerland facility. "If we don't make our own health a priority, we won't
be able to care for anyone else."
"Blue Cross Blue Shield of Arizona supports organizations like Healthy
Women for a Lifetime because we are committed to improving the health of all
Arizonans," said Dr. "I hope that every woman in Arizona takes a look
at these questions and makes an appointment with her primary care provider --
you never know what you might prevent.azblue. The Health and
Wellness section is full of free brochures related to women's health issues. Healthy Women for a Lifetime is dedicated to
the premise that a woman's risk of diseases increases after menopause, but
most of it is preventable., Chief Scientific
Officer and Chairman of the Board of Astralis.

answers health

health disorders

ZLB Behring is a subsidiary of
CSL Limited, a bio-pharmaceutical company, which operates worldwide
from its headquarters in Melbourne, Australia.
The Phase II randomized, double-blind, placebo-controlled study involved
120 patients with moderate to severe psoriasis who received intramuscular
injections of Psoraxine. "We are committed to
understanding whether a different approach, including evaluating a longer
course of therapy and/or modifications to the formulation may yield an outcome
that is more consistent with the results we have seen with patients treated in
Venezuela.

written myositis

"The
expiration of this agreement will allow us to manufacture more of our
intravenous immunoglobulin (IVIG), Carimune (R) NF, to help meet
demand. market will not be reduced when the
contract manufacturing agreement expires."
CEO, James Sharpe noted that, "Although we are disappointed by our
preliminary results , we remain committed to Psoraxine and its future clinical
development.

conditions myositis

S. For more information,
please visit www.

About Healthy Women for a Lifetime
Organized in 1998, Healthy Women for a Lifetime is a nonprofit, public
education network focused on preventing and treating five diseases that
increase women's health risks after menopause: cancer, depression, diabetes,
heart disease and osteoporosis.J.

support immune

PHOENIX, Women face a slue of daily health dangers,
but the good news is a large number of them are preventable.arizonahwl. Gary Smethers, Senior Vice President, Medical Services
and Chief Medical Officer.

auto conditions

AU), and
the American Red Cross announced today that they will not renew their
current contract manufacturing agreement, set to expire on December
31, 2005.com, to find more health statistics and tips.

diseases disorders

American Red Cross and ZLB Behring to Let Manufacturing Agreement Expire; Decision Frees Capacity for Manufacture of Other ZLB Behring Brand Plasma Therapeutic

Based on my medical history, am I at greater risk of heart disease,
stroke, osteoporosis, depression, diabetes and/or breast cancer? How
can I reduce my risks?
2."
Further details about the trial will be available when all data analyses
are complete.

rheumatica myositis

In Celebration of National Women 's Health Week - Top 10 Questions Women Should Ask Their Providers

National Women's
Health Week is May 8 - 14 and the country is asking women across the nation to
pause and consider their health . Should I get a bone density screening? When and how often?
3. Psoraxine(R), administered by intramuscular injection, is a
protein-based therapy that is believed to stimulate cells from the patient's
immune system to reverse the inflammatory process responsible for psoriasis
symptoms .

diseases searching

Should I be screened for colon cancer? At what age and how often?

"Women do a good job of taking care of everyone else in their lives and
all too often put their own needs last," said Lynn Trimble, a member of
Healthy Women for a Lifetime and executive director of the Mental Health
Association of Arizona.

support written

"
As previously announced, "the American Red Cross has decided, upon
a strategic review of our Plasma Services business, that we will exit
the plasma products business so we can focus on our core mission of
insuring a supply of safe blood products," said Jack McGuire ,
Executive Vice President, American Red Cross Biomedical Services. The company's broad portfolio of
life-saving therapeutics is used in the treatment of individuals with
hemophilia and other bleeding disorders, immune deficiency disorders
and inherited emphysema; the prevention of hemolytic diseases for the
newborn; cardiac surgery patients; and shock and burn victims.

Notes to the Editor
Astralis Ltd., a biotechnology company based in New Jersey, focuses on the
research and development of novel treatments for immune system disorders and
skin diseases.

logging diary

Dedicated to improving the quality of life
for patients throughout the world, ZLB Behring provides safe and
effective plasma-derived and recombinant products and offers patients
a wide range of related services. The primary endpoint of the study was a specified
level of improvement of symptoms as measured in accordance with the Psoriasis
Area and Severity Index (PASI), a measurement scale that ranks the severity of
symptoms of patients suffering from psoriasis.D.

health support

By providing public education, the organization
seeks to encourage health plans and other health providers to do a better job
of educating, screening and offering preventive treatments to keep women
healthy as they grow older., Ph.

This press release may contain "forward-looking statements," as defined by
the Private Securities Litigation Reform Act of 1995, regarding Astralis Ltd.

rheumatica conditions

com. Other factors that could cause actual results to differ
materially from anticipated results include, but are not limited to, those
risks and uncertainties detailed in the Company's' annual report on
Form 10-KSB and other reports filed from time to time with the Securities and
Exchange Commission.